Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Psychiatry|October 5, 2006
Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy in U.S. Hispanic and majority Caucasian patientsRoberto Lewis-Fernández, Carlos Blanco, Craig H Mallinckrodt, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|September 13, 2008
The significance of treating somatic symptoms on functional outcome improvement in patients with major depressive disorder: a post hoc analysis of 2 trialsThomas N Wise, Adam L Meyers, Durisala Desaiah, et al.
Statistics in Medicine|October 12, 2005
Comparing onset of antidepressant action using a repeated measures approach and a traditional assessment scheduleCraig H Mallinckrodt, Michael J Detke, Christopher J Kaiser, et al.
Current Medical Research and Opinion|June 15, 2007
Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorderTeresa A Pigott, Apurva Prakash, Lesley M Arnold, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|May 25, 2004
Duloxetine: A New Treatment for the Emotional and Physical Symptoms of DepressionCraig H. Mallinckrodt, David J. Goldstein, Michael J. Detke, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|September 12, 2006
The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trialsJ Craig Nelson, Yili Lu Pritchett, Oleg Martynov, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2004
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trialMichael J Detke, Curtis G Wiltse, Craig H Mallinckrodt, et al.
The Journal of Dermatological Treatment|August 10, 2017
Improvements in psoriasis within different body regions vary over time following treatment with ixekizumabAndrew Blauvelt, Talia M Muram, Kyoungah See, et al.
Biological Psychiatry|March 1, 2006
Attrition in randomized controlled clinical trials: methodological issues in psychopharmacologyAndrew C Leon, Craig H Mallinckrodt, Christy Chuang-Stein, et al.
Frontiers in Medical Technology|July 6, 2026
Efficacy assessment in trials of complex and rare diseases: a comparison between the meta-analytic global statistical test and co-primary analysisSamuel P Dickson, Abe Durrant, Caleb W Dayley, et al.
Pageof 6